BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 38065405)

  • 21. Oncological Outcomes of Lobar Resection, Segmentectomy, and Wedge Resection for T1a Non-Small-Cell Lung Carcinoma: A Systematic Review and Meta-Analysis.
    Ijsseldijk MA; Shoni M; Siegert C; Seegers J; van Engelenburg AKC; Tsai TC; Lebenthal A; Ten Broek RPG
    Semin Thorac Cardiovasc Surg; 2020 Autumn; 32(3):582-590. PubMed ID: 31401180
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lymph node ratio predicts recurrence and survival after R0 resection for non-small cell lung cancer.
    Taylor MD; LaPar DJ; Thomas CJ; Persinger M; Stelow EB; Kozower BD; Lau CL; Jones DR
    Ann Thorac Surg; 2013 Oct; 96(4):1163-1170. PubMed ID: 23998409
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of chronic obstructive pulmonary disease on postoperative recurrence in patients with resected non-small-cell lung cancer.
    Qiang G; Liang C; Xiao F; Yu Q; Wen H; Song Z; Tian Y; Shi B; Guo Y; Liu D
    Int J Chron Obstruct Pulmon Dis; 2016; 11():43-9. PubMed ID: 26766906
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic impact of vascular invasion and standardization of its evaluation in stage I non-small cell lung cancer.
    Hamanaka R; Yokose T; Sakuma Y; Tsuboi M; Ito H; Nakayama H; Yamada K; Masuda R; Iwazaki M
    Diagn Pathol; 2015 Apr; 10():17. PubMed ID: 25884820
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Post-Progression Survival Highly Influences Overall Survival in Driver Gene Mutation/Translocation Negative or Unknown Type of Non-Small Cell Lung Cancer.
    Imai H; Onozato R; Kaira K; Kawashima S; Masubuchi K; Tajima K; Minato K
    Oncology; 2022; 100(2):89-100. PubMed ID: 34844253
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adjuvant Chemotherapy for High-risk Pathologic Stage I Non-Small Cell Lung Cancer.
    Tsutani Y; Imai K; Ito H; Miyata Y; Ikeda N; Nakayama H; Okada M
    Ann Thorac Surg; 2022 May; 113(5):1608-1616. PubMed ID: 34186090
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sleeve lobectomy for non-small cell lung cancer with N1 nodal disease does not compromise survival.
    Berry MF; Worni M; Wang X; Harpole DH; D'Amico TA; Onaitis MW
    Ann Thorac Surg; 2014 Jan; 97(1):230-5. PubMed ID: 24206972
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Challenges in Predicting Recurrence After Resection of Node-Negative Non-Small Cell Lung Cancer.
    Thornblade LW; Mulligan MS; Odem-Davis K; Hwang B; Waworuntu RL; Wolff EM; Kessler L; Wood DE; Farjah F
    Ann Thorac Surg; 2018 Nov; 106(5):1460-1467. PubMed ID: 30031845
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Video-assisted thoracoscopic lobectomy versus stereotactic radiotherapy for stage I lung cancer.
    Hamaji M; Chen F; Matsuo Y; Kawaguchi A; Morita S; Ueki N; Sonobe M; Nagata Y; Hiraoka M; Date H
    Ann Thorac Surg; 2015 Apr; 99(4):1122-9. PubMed ID: 25661580
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lobar or Sublobar Resection for Peripheral Stage IA Non-Small-Cell Lung Cancer.
    Altorki N; Wang X; Kozono D; Watt C; Landrenau R; Wigle D; Port J; Jones DR; Conti M; Ashrafi AS; Liberman M; Yasufuku K; Yang S; Mitchell JD; Pass H; Keenan R; Bauer T; Miller D; Kohman LJ; Stinchcombe TE; Vokes E
    N Engl J Med; 2023 Feb; 388(6):489-498. PubMed ID: 36780674
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sublobar resection versus lobectomy in Surgical Treatment of Elderly Patients with early-stage non-small cell lung cancer (STEPS): study protocol for a randomized controlled trial.
    Yang F; Sui X; Chen X; Zhang L; Wang X; Wang S; Wang J
    Trials; 2016 Apr; 17():191. PubMed ID: 27053091
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early Distant Recurrence in Patients With Resected Stage I Lung Cancer: A Case Series of "Blast Metastasis".
    Ekeke CN; Mitchell C; Schuchert M; Dhupar R; Luketich JD; Okusanya OT
    Clin Lung Cancer; 2021 Jan; 22(1):e132-e135. PubMed ID: 33144072
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of Conventional TNM and Novel TNMB Staging Systems for Non-Small Cell Lung Cancer.
    Haro GJ; Sheu B; Cook NR; Woodard GA; Mann MJ; Kratz JR
    JAMA Netw Open; 2019 Dec; 2(12):e1917062. PubMed ID: 31808928
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased levels of tumor-infiltrating lymphocytes are associated with improved recurrence-free survival in stage 1A non-small-cell lung cancer.
    Horne ZD; Jack R; Gray ZT; Siegfried JM; Wilson DO; Yousem SA; Nason KS; Landreneau RJ; Luketich JD; Schuchert MJ
    J Surg Res; 2011 Nov; 171(1):1-5. PubMed ID: 21571304
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk of recurrence of resected stage I non-small cell lung cancer in elderly patients as compared with younger patients.
    Goodgame B; Viswanathan A; Zoole J; Gao F; Miller CR; Subramanian J; Meyers BF; Patterson AG; Govindan R
    J Thorac Oncol; 2009 Nov; 4(11):1370-4. PubMed ID: 19692932
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk Factors for Local and Distant Recurrence After Surgical Treatment in Patients With Non-Small-Cell Lung Cancer.
    Dziedzic DA; Rudzinski P; Langfort R; Orlowski T;
    Clin Lung Cancer; 2016 Sep; 17(5):e157-e167. PubMed ID: 26831834
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Persistent Problem of Local/Regional Failure After Surgical Intervention for Early-Stage Lung Cancer.
    Judy GD; Kaidar-Person O; Deal A; Wang Y; Migliardi A; Long J; Haithcock B; Marks LB
    Ann Thorac Surg; 2018 Aug; 106(2):382-389. PubMed ID: 29723532
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oncologic outcomes of segmentectomy compared with lobectomy for clinical stage IA lung adenocarcinoma: propensity score-matched analysis in a multicenter study.
    Tsutani Y; Miyata Y; Nakayama H; Okumura S; Adachi S; Yoshimura M; Okada M
    J Thorac Cardiovasc Surg; 2013 Aug; 146(2):358-64. PubMed ID: 23477694
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcomes of sublobar resection vs lobectomy for invasive clinical stage T1N0 non-small-cell lung cancer: A propensity-match analysis.
    Wald O; Sadeh BM; Bdolah-Abram T; Erez E; Shapira OM; Izhar U
    Cancer Rep (Hoboken); 2021 Jun; 4(3):e1339. PubMed ID: 33570255
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinicopathological variables influencing overall survival, recurrence and post-recurrence survival in resected stage I non-small-cell lung cancer.
    Wang C; Wu Y; Shao J; Liu D; Li W
    BMC Cancer; 2020 Feb; 20(1):150. PubMed ID: 32093621
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.